| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/10/2004 | WO2004076655A1 Modified nitrilases and their use in methods for the production of carboxylic acids |
| 09/10/2004 | WO2004076648A2 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 09/10/2004 | WO2004076645A2 Compositions and methods for cytomegalovirus treatment |
| 09/10/2004 | WO2004076638A2 Polynucleotides and polypeptides in plants |
| 09/10/2004 | WO2004076636A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 09/10/2004 | WO2004076635A2 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/10/2004 | WO2004076633A2 Hypoxia inducible vegf plasmid for ischemic disease |
| 09/10/2004 | WO2004076630A2 Covalent modification of rna for in vitro and in vivo delivery |
| 09/10/2004 | WO2004076629A2 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES |
| 09/10/2004 | WO2004076627A2 Method of using adenoviral vectors with increased persistence in vivo |
| 09/10/2004 | WO2004076626A2 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 09/10/2004 | WO2004076625A2 Method of identifying plant cells transformed with a gene |
| 09/10/2004 | WO2004076623A2 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth |
| 09/10/2004 | WO2004076622A2 Regulation of gene expression by dna interference |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076620A2 Human antibodies specific for interleukin 15 (il-15) |
| 09/10/2004 | WO2004076619A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 09/10/2004 | WO2004076618A2 Genetically modified non-human mammals and cells |
| 09/10/2004 | WO2004076617A2 Method for the production of polyunsaturated fatty acids |
| 09/10/2004 | WO2004076616A2 Arabidopsis promoters |
| 09/10/2004 | WO2004076615A2 Immunomodulating probiotic compounds |
| 09/10/2004 | WO2004076613A2 Human nucleic acid sequences from carcinomas of the bladder |
| 09/10/2004 | WO2004076483A1 Transcriptional factor inducing apoptosis in cancer cell |
| 09/10/2004 | WO2004076482A1 Soluble factor secreted by endothelial cells in blood vessels |
| 09/10/2004 | WO2004076481A2 Hypoallergenic der p 1 and der p 3 proteins from dermatographoides pteronyssinus |
| 09/10/2004 | WO2004076480A1 Tumour marker and its use |
| 09/10/2004 | WO2004076472A1 Novel guanosine derivatives and use thereof |
| 09/10/2004 | WO2004075924A1 Gene transfer promoter and gene tansfer composition containing the same |
| 09/10/2004 | WO2004075861A2 Recombinant adeno-associated virus production |
| 09/10/2004 | WO2004075850A2 Polyvalent immunogen |
| 09/10/2004 | WO2004075842A2 Mrp3 genes and uses thereof |
| 09/10/2004 | WO2004075836A2 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/10/2004 | WO2004075831A2 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 09/10/2004 | WO2004075635A2 Crystal structure of the ternary compelex of 14-3-3, fusicoccin and plasma membrane atpase and methods for designing new herbicides |
| 09/10/2004 | WO2004061078A3 Method to identify and analyze genes having modified expression in activated cells with secretory lysosomes |
| 09/10/2004 | WO2004060869A3 Methods and compositions for catalytic dna exchange in a sequence manner |
| 09/10/2004 | WO2004058978A3 Protein purification means |
| 09/10/2004 | WO2004058175A3 Novel use of liver x receptor agonists |
| 09/10/2004 | WO2004056173A3 Generation of plants with altered oil content |
| 09/10/2004 | WO2004055177A3 Artificial esterases |
| 09/10/2004 | WO2004053092A3 Human pellino polypeptides |
| 09/10/2004 | WO2004052909A3 Lna-cpg conjugates |
| 09/10/2004 | WO2004044204A3 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 09/10/2004 | WO2004044147A3 Modified dendritic cells |
| 09/10/2004 | WO2004044131A8 Cross-linked oligomeric compounds and their use in gene modulation |
| 09/10/2004 | WO2004042023A3 Stem cell libraries |
| 09/10/2004 | WO2004039841A3 Trimeric binding proteins for trimeric cytokines |
| 09/10/2004 | WO2004037278A3 Delocalization molecules and use thereof |
| 09/10/2004 | WO2004033622A3 Preservation of rna and morphology in cells and tissues |
| 09/10/2004 | WO2004031397A3 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value |
| 09/10/2004 | WO2004031210A3 Optimized multi-epitope constructs and uses thereof |
| 09/10/2004 | WO2004029287A3 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 09/10/2004 | WO2004023867A3 Transgenic cancer models in fish |
| 09/10/2004 | WO2004021772A3 Immune cloning and uses thereof |
| 09/10/2004 | WO2004020579A3 Method of humanizing immune system molecules |
| 09/10/2004 | WO2004018694A3 Method for producing ketocarotinoids in genetically modified organisms |
| 09/10/2004 | WO2004017044A3 Chimeric protein |
| 09/10/2004 | WO2004009835A3 Method for identifying cellular growth inhibitors |
| 09/10/2004 | WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 09/10/2004 | WO2004003019A3 Immunoglobin single variant antigen-binding domains and dual-specific constructs |
| 09/10/2004 | WO2003100021A3 Methods and dna constructs for high yield production of polypeptides |
| 09/10/2004 | WO2003099842A3 Compositions and methods of use for a bombesin peptide |
| 09/10/2004 | WO2003093296A3 Kinase anchor protein muteins, peptides thereof, and related methods |
| 09/10/2004 | WO2003092594A3 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use |
| 09/10/2004 | WO2003087123A3 Methods and kits for testing mutagenicity |
| 09/10/2004 | WO2003084982A3 Functionalized compositions for improved immobilization |
| 09/10/2004 | WO2003080807A8 Compositions and methods for suppressing eukaryotic gene expression |
| 09/10/2004 | WO2003078449A3 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
| 09/10/2004 | WO2003076643A3 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/10/2004 | WO2003076579A3 Cancer-linked gene as target for chemotherapy |
| 09/10/2004 | WO2003073839A8 Expression of lysosomal enzymes in plant seeds |
| 09/10/2004 | WO2003070897A3 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/10/2004 | WO2003068967A3 Novel retina specific human proteins wdr17, net01, protein kinase a203, protein kinase mak a194, protein a105, protein a106 and c12orf3variants |
| 09/10/2004 | WO2003066801A3 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system. |
| 09/10/2004 | WO2003065146A3 Methods for placing, accepting, and filling orders for products and services |
| 09/10/2004 | WO2003064618A3 Immune response replication in cloned animals |
| 09/10/2004 | WO2003045230A3 Novel compositions and methods for cancer |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | WO2002098890A3 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/10/2004 | WO2002094999A3 Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof |
| 09/10/2004 | WO2002094780A3 Kinases and phosphatases |
| 09/10/2004 | WO2002092840A3 Agents that regulate apoptosis |
| 09/10/2004 | CA2630024A1 Arabidopsis promoters |
| 09/10/2004 | CA2517294A1 Method of using adenoviral vectors with increased persistencein vivo |
| 09/10/2004 | CA2517285A1 Transcriptional factor inducing apoptosis in cancer cell |
| 09/10/2004 | CA2517259A1 Induction of methylation of cpg sequences by dsrnas in mammalian cells |
| 09/10/2004 | CA2517253A1 Method for the production of polyunsaturated fatty acids |
| 09/10/2004 | CA2517235A1 Methods and constructs for evaluation of rnai targets and effector molecules |
| 09/10/2004 | CA2517082A1 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response |
| 09/10/2004 | CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 09/10/2004 | CA2517062A1 Vaccines derived from epithelial cell mucin muc-1 |
| 09/10/2004 | CA2517052A1 Polyvalent immunogen |
| 09/10/2004 | CA2516727A1 Hypoxia inducible vegf plasmid for ischemic disease |
| 09/10/2004 | CA2516645A1 Abiotic stress responsive plant transcription factor polynucleotides and polypeptides and use thereof for generating transgenic plants |
| 09/10/2004 | CA2516640A1 Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis |
| 09/10/2004 | CA2516619A1 Glutamate transport modulatory compounds and methods |
| 09/10/2004 | CA2516378A1 Human antibodies specific for interleukin 15 (il-15) |
| 09/10/2004 | CA2516373A1 Methods and constructs for increasing the content of selected amino acids in seeds |
| 09/10/2004 | CA2515916A1 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/10/2004 | CA2515586A1 Regulation of gene expression by dna interference |